This exploratory post hoc analysis investigated the relative changes in glycated haemoglobin (HbA1c) in patients with type 2 diabetes mellitus (T2DM) treated with dulaglutide versus active comparators across a continuous range of baseline HbA1c values using data from three phase III randomised controlled trials.
Change in HbA1c Across the Baseline HbA1c Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents / Gentilella, Raffaella; Romera, Irene; Nicolay, Claudia; Buzzetti, Raffaella; Vázquez, Luis Alberto; Sesti, Giorgio. - In: DIABETES THERAPY. - ISSN 1869-6961. - 10:3(2019), pp. 1113-1125. [10.1007/s13300-019-0625-3]
Change in HbA1c Across the Baseline HbA1c Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents
Buzzetti, Raffaella;Sesti, Giorgio
2019
Abstract
This exploratory post hoc analysis investigated the relative changes in glycated haemoglobin (HbA1c) in patients with type 2 diabetes mellitus (T2DM) treated with dulaglutide versus active comparators across a continuous range of baseline HbA1c values using data from three phase III randomised controlled trials.| File | Dimensione | Formato | |
|---|---|---|---|
|
Gentilella_Change-In-HbA1c_2019.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
698.87 kB
Formato
Adobe PDF
|
698.87 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
